Evotec SE : Slight miss at the adj. EBITDA level – 2024 guidance not h...

>2023 adj. EBITDA slightly below expectations - Evotec reported FY 2023, with revenue broadly in line with expectations at € 781.4m (+4%) vs cons of € 784.9m and our estimates of € 784.8m. The company’s adjusted EBITDA of € 66.4m (-34.7%) was within its guidance of € 60-80m but slightly below cons of € 69m and below our estimates of € 69.4m.2024 guidance not helpful at this stage - For 2024 the company is guiding a double digit increase of its top li...

ABGSC Shipping Daily 24 April

Tankers and LPG down, mixed dry bulk market. Shipping peer group trades at P/NAV 0.81x. HAUTO Q1: Red Sea diversions is a smaller problem than expected.

CM.com : Buckle up, CM.com is restarting its growth engines

>We cut our gross profit forecast by 10%, but increase EBITDA by 7% - FY 2023 revenues fell materially below our forecast as the shift from growth to value had a bigger impact on revenues than anticipated. This was partially mitigated by slightly higher gross margins and much better cost control. In this report we lower our revenue forecast by 15% and our gross profit forecast by 10%. Our EBITDA forecast for FY 2024-25 increases by 7%.Restarting the growt...

Roche Holding : Q1 in line - Guidance confirmed, forex less unfavourab...

>Q1 saved by Vabysmo - Q1 sales at group level were in line with the consensus, up 2% cc (-6% CHF). The pharmaceuticals (+0.9% vs cons.) business was up 2% cc (-6% CHF) largely driven by Vabysmo (96%, 11% vs cons.) and Phesgo (+61%, 23% vs cons.), to a lesser extent. Flagship products like Ocrevus (1.3%, -0.4% vs cons.), Hemlibra (0.6%, -3.1% vs cons.) and even Tecentriq (-6%, -5.5% vs cons.) delivered clearly disappointing performances. The diagnostics activity grew...

Tikehau Capital : Bonne collecte au T1, mais le groupe atrophie encore...

>Collecte nette de 1.5 Md€ et forte croissance des AUM - Tikehau Capital affiche des AuM pour le T1 2024 en AM à 44.4 Md€, en hausse de 3% (+ 1.2 Md€) vs fin 2023 et des AuM globaux (incluant le bilan) en hausse de 3% (+1.3 Md€). Cette hausse au T1 est la résultante des quatre facteurs impactant les AuM : +1.5 Md€ de collecte nette (vs. 1.2 Md€ au T1 2023), soit +6.8 Md€ sur 12 mois. - 0.5 Md€ de distribution. + 0.4 Md€ d’effets de marchés et -0.1 ...

Coffee, Croissants & Credit/Iberdrola, Enel, KPN, Heimstaden Bostad, a...

Utilities - Iberdrola: 1Q24 beats estimates. Enel misses carbon reduction target on SLB bonds

Benelux Morning Notes

ASM International: 1Q24 results - better on all fronts. Heineken: Uphill from here. KPN: 1Q24 in line, guidance slightly increased on Youfone acquisition. Melexis: 1Q24 results in line a relief. Universal Music Group: Spotify 1Q24 Results and guidance beat on margins. Vopak: Good progress to start the year. Wereldhave: 1Q24 LFL slows sharply

Weekly bulletin - 15 April - 19 April 2024

Bulgarian stock indexes ended last week on a negative note, after the tone in global markets seems to have shifted with continuing uncertainty and volatility. The leading local index SOFIX lost 0.5% to close at 805.96, as extended indexes BGBX40 (164.27) and BGTR30 (809.49) declined by -0.5% and -0.8% respectively, repeating benchmark presentation. The weekly top performer within our list of selected companies was the industrial Alcomet (ALCM, BGN 7.0, +7.7%), followed by Speedy (SPDY, BGN 165...

High Yield Bonds Daily

Intrum, Heimstaden Bostad, Heimstaden AB, Pandion

Air Liquide : Q1 2024 group comparable sales growth in line with conse...

>Q1 2024 likely to be the weakest quarter, no uptick in European LI activities yet, pricing in IM decreased to 3.7% (as expected & fuelled by energy price indexation) - Air Liquide reported Q1 2024 group comparable sales growth of 2.1% y-o-y (G&S: +2.0% vs. css: +2.4%), hence perfectly matching consensus estimate of 2.1% (FX: -3.9%, Energy: -5.5%). Europe and Asia have been the weakest regions with -1.6% and -0.9% comparable sales growth in Q1 2024, respectively. Ind...

KPN : Q1 results marginally ahead of consensus and FY guidance raised

>Q1 results show positive momentum – FY guidance raised - In its Q1 earnings release, KPN reported group revenues and adjusted EBITDAaL of €1,377m (+3.3%) and €605m (+3.6%) respectively. This compares with consensus estimates of €1,376m (we at €1,377m) and € 602m (we at €599m) respectively. So results are marginally ahead of consensus. Group capex came in at €302m (css: € 301m) and FCF at €154m (-5.8% yoy with consensus at €173m and we at € 185m, the difference is ex...

Morning Bulletin - 23 April 2024

The Bulgarian equity market met the opposite volatile moves of Monday’s session compared to Friday’s as Chimimport (CHIM, BGN 0.68, -2.86%) and Central Cooperative Bank (CCB, BGN 1.49, -3.25%) erased the gains from previous session, while Zlaten Lev Holding (HLEV, BGN 4.30, +19.44%) and M+S Hydraulic (MSH, BGN 11.10, +2.78%) recovered with the same percentages. The major indexes rebounded, reflecting the continues reactions from positive news of Bulgarian-American Bank’s (BACB, BGN 11.70, +3.54%...

Morning Bulletin - 24 April 2024

The Bulgarian equity market had a volatile session on Tuesday and finally the major indexes settled in a range between -0.18% and +0.20%. 370K shares of First Investment Bank (FIB, BGN 2.78, +4.51%) were offered in early hours and attracted significant buying interest not only in the name as 6 out 15 names registered volumes much higher than the 3-months average – Doverie United Holding (DUH, BGN 8.22, -2.61%), Shelly Group (SLYG, BGN 68.00, 0.00%). The trading activity was concentrated on the b...

INVEST SECURITIES - AIRWELL :Visions MT inchangées, prévisions CT prud...

INVEST SECURITIES - COVIVIO : Un T1 de bonne facture - ACHAT, OC 54,3...

Home Invest Belgium NV: 1 director

A director at Home Invest Belgium NV bought 1,025,850 shares at 13.080EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Vivakor Inc: 1 director

A director at Vivakor Inc bought 168,000 shares at 1.325USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...